Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Back Pain and CYP2D6[original query] |
|---|
| O-demethylation of codeine to morphine inhibited by low-dose levomepromazine. European journal of clinical pharmacology 2009 Mar . Vevelstad M, Pettersen S, Tallaksen C, Brørs O |
| Distribution of HLA-B27 and CYP2D6*4 mutations in the middle Black Sea area (Tokat) of Turkey. Genetics and molecular research : GMR 2011 10 (4): 3987-91. Sahin S, Aydogan L, Benli I, Ozyurt |
| Effect of single-dose imipramine on chronic low-back and experimental pain. A randomized controlled trial. PloS one 2018 5 13 (5): e0195776. Schliessbach Jürg, Siegenthaler Andreas, Bütikofer Lukas, Limacher Andreas, Juni Peter, Vuilleumier Pascal H, Stamer Ulrike, Arendt-Nielsen Lars, Curatolo Miche |
| CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort. Pharmacogenomics and personalized medicine 2018 11 179-191. Dagostino Concetta, Allegri Massimo, Napolioni Valerio, D'Agnelli Simona, Bignami Elena, Mutti Antonio, van Schaik Ron |
| Nephrotoxicity in a Patient With Inadequate Pain Control: Potential Role of Pharmacogenetic Testing for Cytochrome P450 2D6 and Apolipoprotein L1. Frontiers in pharmacology 2020 1 10 1511. Tillman Emma M, Skaar Todd C, Eadon Michael |
| Dataset of the first report of pharmacogenomics profiling in an outpatient spine setting. Data in brief 2021 3 35 106832. Cottrill Ethan, Pennington Zach, Lai Chun Wan Jeffrey, Ehresman Jeff, Jiang Bowen, Ahmed A Karim, Zhu Alex, Perdomo-Pantoja Alexander, Sciubba Daniel M, Witham Timothy, Lee Chun Hin, MacDonald Kevin, Theodore Nichol |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: